Evidence map›Paper›PMID 29560123›Full record

ArticleOncotarget2018

Lianghua Fang, Hui Chen, Zhenya Tang, Neda Kalhor, Ching-Hua Liu, Hui Yao, Shimin Hu, Pei Lin, Jin Zhao, Raja Luthra and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Non-small cell lung cancer withFrontiers in oncology · 2023
    Pooled it
  2. Plasma ddPCR for the detection ofTherapeutic advances in medical oncology · 2024
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Lianghua FangDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hui ChenDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Zhenya TangDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Neda KalhorDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ching-Hua LiuDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hui YaoDepartment of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Shimin HuDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pei LinDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jin ZhaoDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Raja LuthraDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rajesh R SinghDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mark J RoutbortDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
David HongDepartment of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
L Jeffrey MedeirosDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Xinyan LuDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

To investigate the prognostic impact of

Indexed as

distant metastasisMET FISH reporting criteriaMET gene amplificationnon-small cell lung cancer

Identifiers

PMID29560123
PMCPMC5849187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.